Skip to main content

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

AKRO holding history

Akero Therapeutics, Inc. in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKRO overviewAll 13F holders of AKROFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q1 2025
Holdings of AKRO by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−7,684−100.0%Sold outHolders
Q3 20257,684$364.8K<0.1%−766−9.1%ReducedHolders
Q2 20258,450$450.9K<0.1%+1,229+17.0%AddedHolders
Q1 20257,221$292.3K<0.1%+7,221NewHolders